Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives

Expert Rev Gastroenterol Hepatol. 2015;9(8):1039-53. doi: 10.1586/17474124.2015.1049155. Epub 2015 May 20.

Abstract

Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the identification of those patients with the worst prognosis is mandatory. Liver biopsy is still the diagnostic gold standard, even if it is associated to a significant rate of complications; moreover, the interpretation of histological samples is not always univocal. Several non-invasive alternative scores have been proposed for the diagnostic approach to non-alcoholic fatty liver disease. This article evaluates the performance of the currently available non-invasive diagnostic strategies. The authors also suggest a potential diagnostic algorithm, with two or more non-invasive techniques, to increase the overall accuracy for identifying patients with worst prognosis, and to minimize the recourse to liver biopsy.

Keywords: NAFLD; NASH; Non-invasive diagnosis; liver fibrosis; steatosis; transient elastography.

Publication types

  • Review

MeSH terms

  • Biomarkers / blood*
  • Elasticity Imaging Techniques*
  • Humans
  • Liver Cirrhosis / diagnosis*
  • Magnetic Resonance Imaging
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Tomography, X-Ray Computed

Substances

  • Biomarkers